1Pateron D,Beyre P,Laperche T,et al.Elevated circulating cardiac troponin Ⅰ in patients with cirrhosis[J].Hepatology,1999,29:640-643.
2Girgrah N,Reid G,MacKenzie S,et al.Cirrhotic cardiomyopathy:does it contribute to chronic fatigue and decreased health-related quality of life in cirrhosis[J].Can J Gastroenterol,2003,17(9):545-551.
4Moller S,Henriksen JH.Cirrhotic cardiomyopathy:a pathophysiological review of circulatory dysfunction in liver disease[ J].Heart,2002,87(1):9-15.
5Gerbes AL,Remien J,Jungst D,et al.Evidence for down-regulation of β2-adrenoceptors in cirrhotic patients with severe ascites[ J].Lancet,1986,1:1409-1410.
6Ma ZH,Meddings JB,Lee SS.Membrance physical properties determine β-adrenergic receptor function in cirrhotic rats[J].Am J Physiol,1994,267:G87-G93.
7Groszmann RJ.Hyperdynamic circulation of liver disease 40 years later:pathophysiology and clinical consequences [ J].Hepatology,1994,20:1359-1363.
8Pozzi M,Osculati G,Boari G,et al.Time course of circulative and humoral effects of rapid total paracentesis in cirrhotic patients with tense,refractory ascites[ J].Gastroenterology,1997,106:709-719.
9Pozzi M,Carugo,S,Boari G,et al.Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites [J].Hepatology,1997,26:113-120.
